Frontlight ResearchEarly access
Trial site
University of Cincinnati Gardner Neuroscience Institute
- 3running trials
- 4closed trials
The trials here
What the 7 trials at this site are about, from their registry records.
- Conditions
- Duchenne muscular dystrophy2 trials
- Myotonic dystrophy2 trials
- ALS (motor neurone disease)1 trial
- Frontotemporal dementia1 trial
- Myasthenia gravis1 trial
- Pompe disease1 trial
- Phase
- Phase 35 trials
- Phase 22 trials
- Status
- Completed3 trials
- Enrolling by invitation2 trials
- Active, not recruiting1 trial
- Terminated1 trial
- Lead sponsor
- Avidity Biosciences, Inc.2 trials
- Edgewise Therapeutics, Inc.2 trials
- Alector Inc.1 trial
- Amicus Therapeutics1 trial
- Regeneron Pharmaceuticals1 trial
Running trials
Enrolling by invitation
Global Open-Label Extension Study of Del-desiran for the Treatment of DM1
Enrolling by invitation
Open-Label Extension of EDG-5506 in Participants With Becker Muscular Dystrophy
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Duchenne muscular dystrophy1 recruiting
- Myotonic dystrophy1 recruiting
Closed trials
Completed
Terminated
Completed
Phase 2 Study of EDG-5506 in Becker Muscular Dystrophy (GRAND CANYON)
Completed
Site data: ClinicalTrials.govUpdated 15 Nov 2026